This article was written by Follow Striving to uncover long-term investment opportunities (10+ years) through in-depth research and analysis. Nexus Research seeks to evaluate...
This article was written by Follow Manika is a macroeconomist with over 20 years of experience in industries including investment management, stock broking, investment...
This article was written by Follow Roberts Berzins has over a decade of experience in the financial management helping top-tier corporates shape their financial...
What’s the best-performing sector in 2023? You might say something tech-related. While that is true among large-cap US equities, small and mid-sized companies within...
At a Glance In light of Lyra Therapeutics’ (NASDAQ:LYRA) recent financial and clinical data, investors face a complex investment landscape. On the clinical side,...
After Lucid Group (NASDAQ:LCID) disappointed multiple times with its delivery achievements in FY 2023 and dropped its EV prices by a considerable percentage, the...
The potential Exxon Mobil (XOM) deal to acquire Pioneer Natural Resources (PXD) should make Devon Energy (NYSE:DVN) even more appealing. The independent energy company...
Big Dividends PLUS, Blue Harbinger The BlackRock Health Sciences Term Trust (NYSE:BMEZ) is a closed-end fund (“CEF”) that recently announced a distribution cut, and...